640 vs H7T2: Side-by-Side Comparison
Compare China Resources Pharmaceutical Group Limited (640) and HUTCHMED (CHINA) LS-1 (H7T2) side by side: market cap EUR 2.97B vs EUR 1.47B, P/E 5.9 vs 3.6. Financials, growth and model signals on Bullrun.
| Metric | 640 | H7T2 |
|---|---|---|
| Company | China Resources Pharmaceutical Group Limited | HUTCHMED (CHINA) LS-1 |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 2.97B | EUR 1.47B |
| P/E ratio | 5.9 | 3.6 |
| Dividend yield | 5.14% | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 269.57B | EUR 548.51M |
| Revenue growth YoY | +4.6% | -13.0% |
| Net income | EUR 4.05B | EUR 456.91M |
| Gross margin | 16.5% | 38.7% |
| Diluted EPS | 0.64 | 0.53 |